Antimicrobial Peptides and Their Analogs: Searching for New Potential Therapeutics
Perspectives in Medicinal Chemistry · 2014
DOI: 10.4137/pmc.s13215 ↗Kurz gefasst
Fachartikel in der Zeitschrift Perspectives in Medicinal Chemistry, 2014. Verfasst von Krystyna Midura-Nowaczek und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Organic Chemistry, Medical University of Bialystok, Bialystok, Poland. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 93 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Antimicrobial peptides (AMPs) are an essential part of innate immunity. These compounds have been considered as potential therapeutics because of their broad-spectrum activities and proven ability to avoid antimicrobial resistance, but their clinical and commercial developments have some limitations, such as susceptibility to proteases and a high cost of peptide production. To overcome these problems, many researchers have tried to develop short active peptides, their modifications and mimics with better properties while retaining their basic features of natural AMPs such as cationic charge and the amphipathic structure.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Organic Chemistry, Medical University of Bialystok, Bialystok, Poland.
Zitieren
APA
Midura-Nowaczek, K., & Markowska, A. (2014). Antimicrobial Peptides and Their Analogs: Searching for New Potential Therapeutics. Perspectives in Medicinal Chemistry. https://doi.org/10.4137/pmc.s13215
Vancouver
Midura-Nowaczek K, Markowska A. Antimicrobial Peptides and Their Analogs: Searching for New Potential Therapeutics. Perspectives in Medicinal Chemistry. 2014. doi:10.4137/pmc.s13215
BibTeX
@article{MiduraNowaczek2014,
author = {Midura-Nowaczek, Krystyna and Markowska, Agnieszka},
title = {Antimicrobial Peptides and Their Analogs: Searching for New Potential Therapeutics},
journal = {Perspectives in Medicinal Chemistry},
year = {2014},
doi = {10.4137/pmc.s13215}
}
EUVIMED